Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma – significance of potentially retained stemness by Ju-Yoon Yoon, Christine Brezden-Masley, Catherine J. Streutker

Get full text

Best Practices for Managing Patients with Unresectable Metastatic Gastric and Gastroesophageal Junction Cancer in Canada by Stephanie Snow, Denise Gabrielson, Howard Lim, Mustapha Tehfe, Christine Brezden-Masley

Get full text

Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population by Amir Abadir, Catherine Streutker, Christine Brezden-Masley, Andrea Grin, Young-In Kim

Get full text

Intravenous iron and iron deficiency anemia in patients with gastrointestinal cancer: A systematic review. by Shankavi Nandakumar, Navreet Singh, Alliya Remtulla Tharani, Maya Pankiw, Christine Brezden-Masley

Get full text

Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective by Cristiano Ferrario, Anna Christofides, Anil Abraham Joy, Kara Laing, Karen Gelmon, Christine Brezden-Masley

Get full text

Real-World Treatment Patterns and Clinical Outcomes among Patients Receiving CDK4/6 Inhibitors for Metastatic Breast Cancer in a Canadian Setting Using AI-Extracted Data by Ruth Moulson, Guillaume Feugère, Tracy S. Moreira-Lucas, Florence Dequen, Jessica Weiss, Janet Smith, Christine Brezden-Masley

Get full text

Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer by Mita Manna, Michelle Brabant, Rowen Greene, Michael Dean Chamberlain, Aalok Kumar, Nimira Alimohamed, Christine Brezden-Masley

Get full text

The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based R... by Colin Sue-Chue-Lam, Christine Brezden-Masley, Rinku Sutradhar, Amy Y. X. Yu, Nancy N. Baxter

Get full text

Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospecti... by Colin Sue-Chue-Lam, Christine Brezden-Masley, Rinku Sutradhar, Amy Ying Xin Yu, Nancy Noel Baxter

Get full text

A population‐based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple‐negative breast cancer by Christine Brezden‐Masley, Kelly E. Fathers, Megan E. Coombes, Behin Pourmirza, Cloris Xue, Katarzyna J. Jerzak

Get full text

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm by Charlie Yang, Christine Brezden-Masley, Anil Abraham Joy, Sandeep Sehdev, Shanu Modi, Christine Simmons, Jan-Willem Henning

Get full text

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective by Jan-Willem Henning, Christine Brezden-Masley, Karen Gelmon, Stephen Chia, Shane Shapera, Micheal McInnis, Daniel Rayson, Jamil Asselah

Get full text

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

Get full text

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis by Florence R. Wilson, Megan E. Coombes, Quinlan Wylie, Mariya Yurchenko, Christine Brezden-Masley, Brian Hutton, Becky Skidmore, Chris Cameron

Get full text

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc... by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

Get full text

HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review by Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton, Sandeep Sehdev

Get full text

Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study by Alexandra Moskalewicz, Amy Di Tomaso, Jacob J. Kachura, Samantha Scime, Rosane Nisenbaum, Ronita Lee, Rashida Haq, Christine Derzko, Christine Brezden-Masley

Get full text

Randomised controlled trials of non-pharmacological interventions to improve patient-reported outcomes of colonoscopy: a scoping review by Nancy N Baxter, Jill Tinmouth, Diego Llovet, Teruko Kishibe, Colin Sue-Chue-Lam, Matthew Castelo, Christine Brezden-Masley, Amina Benmessaoud, Amy YX Yu

Get full text

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis by Florence R. Wilson, Megan E. Coombes, Christine Brezden-Masley, Mariya Yurchenko, Quinlan Wylie, Reuben Douma, Abhishek Varu, Brian Hutton, Becky Skidmore, Chris Cameron

Get full text

Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada by Stephanie Snow, Christine Brezden-Masley, Michael D. Carter, Neesha Dhani, Cassandra Macaulay, Ravi Ramjeesingh, Michael J. Raphael, Monika Slovinec D’Angelo, Filomena Servidio-Italiano

Get full text